Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes

Molecular Endocrinology

Volumn 29, Issue 4, 2015, Pages 583-596

  Mangmool, Supachoke ^a   Hemplueksa, Piriya ^a   Parichatikanond, Warisara ^a   Chattipakorn, Nipon ^b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Faculty of Medicine   (Thailand)

^c CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CATALASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUTATHIONE PEROXIDASE 1; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; EPAC PROTEIN, RAT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PEPTIDE; SMALL INTERFERING RNA; VENOM;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXCHANGE PROTEIN ACTIVATED BY CAMP DEPENDENT SIGNALING PATHWAY; HEART MUSCLE CELL; HEART PROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; GENETICS; METABOLISM;

ANIMALS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HYDROGEN PEROXIDE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; VENOMS;

EID: 84926335902     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1346     Document Type: Article

References (47)

1. Yu Z, Jin T. New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP- 1). Cell Signal. 2010;22(1):1-8
2. Wei Y, Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 1995;358(3): 219-224
3. Sonne DP, Engstrom T, Treiman M. Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. Regul Pept. 2008;146(1-3):243-249
4. Timmers L, Henriques JP, de Kleijn DP, et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol. 2009;53(6): 501-510
5. Nikolaidis LA, Elahi D, Hentosz T, et al. Recombinant glucagonlike peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation. 2004;110(8):955-961
6. Wang SX, Xie Y, Zhou X, et al. [Effect of glucagon-like peptide-1 on hypoxia-reoxygenation induced injury in neonatal rat cardiomyocytes]. Zhonghua Xin Xue Guan Bing Za Zhi. 2010;38(1):72-75
7. Maack C, Kartes T, Kilter H, et al. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation. 2003;108(13):1567-1574
8. Fukui T, Yoshiyama M, Hanatani A, Omura T, Yoshikawa J, Abe Y. Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem Biophys Res Commun. 2001;281(5):1200-1206
9. Holz GG. Epac: A new cAMP-binding protein in support of glucagon- like peptide-1 receptor-mediated signal transduction in the pancreatic b-cell. Diabetes. 2004;53(1):5-13
10. Fehmann HC, Goke R, Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev. 1995;16(3):390-410
11. Holz GG, Leech CA, Habener JF. Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic b-cells by the insulinotropic hormone glucagon-like peptide-1. J Biol Chem. 1995; 270(30):17749-1757
12. Mukai E, Fujimoto S, Sato H, et al. Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto- Kakizaki rat islets in an Epac-dependent manner. Diabetes. 2011; 60(1):218-226
13. Kwon G, Pappan KL, Marshall CA, Schaffer JE, McDaniel ML. CAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells. J Biol Chem. 2004; 279(10):8938-8945
14. Oeseburg H, De Boer RA, Buikema H, Van Der Harst P, Van Gilst WH, Sillje HH. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol. 2010;30(7): 1407-1414
15. Vila Petroff MG, Egan JM, Wang X, Sollott SJ. Glucagon-like peptide- 1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res. 2001;89(5):445-452
16. Gezginci-Oktayoglu S, Sacan O, Yanardag R, Karatug A, Bolkent S. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice. Peptides. 2011; 32(2):223-231
17. Pereira L, Metrich M, Fernandez-Velasco M, et al. The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J Physiol. 2007; 583(Pt 2):685-694
18. Mangmool S, Shukla AK, Rockman HA. _-Arrestin-dependent activation of Ca(2_+)/calmodulin kinase II after b(1)-adrenergic receptor stimulation. J Cell Biol. 2010;189(3):573-587
19. Zhu WZ, Wang SQ, Chakir K, et al. Linkage of b1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest. 2003;111(5):617-625
20. Wei Q, Sun YQ, Zhang J. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic b-cell line. Peptides. 2012;37(1):18-24
21. Noyan-Ashraf MH, Momen MA, Ban K, et al. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes. 2009;58(4):975-983
22. Bode HP, Moormann B, Dabew R, Goke B. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic b-cells independently of protein kinase A. Endocrinology. 1999;140(9):3919-3927
23. Skoglund G, Hussain MA, Holz GG. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. Diabetes. 2000;49(7):1156-1164
24. Bos JL. Epac proteins: Multi-purpose cAMP targets. Trends Biochem Sci. 2006;31(12):680-686
25. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 1998;396(6710):474-477
26. Metrich M, Lucas A, Gastineau M, et al. Epac mediates b-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res. 2008; 102(8):959-965
27. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res. 2005;97(7):655-662
28. Ulucan C, Wang X, Baljinnyam E, et al. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am J Physiol Heart Circ Physiol. 2007;293(3):H1662-H1672
29. Pereira L, Cheng H, Lao DH, et al. Epac2 mediates cardiac b1- adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. Circulation. 2013;127(8):913-922
30. Kim M, Platt MJ, Shibasaki T, et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med. 2013;19(5):567-575
31. Anderson ME. CaMKII and a failing strategy for growth in heart. J Clin Invest. 2009;119(5):1082-1085
32. Zhang R, Khoo MS, Wu Y, et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med. 2005;11(4): 409-417
33. Yano S, Yano N. Regulation of catalase enzyme activity by cell signaling molecules. Mol Cell Biochem. 2002;240(1-2):119-130
34. Das KC, Guo XL, White CW. Protein kinase Cb-dependent induction of manganese superoxide dismutase gene expression by microtubule- active anticancer drugs. J Biol Chem. 1998;273(51):34639-34645
35. Ban K, Kim KH, Cho CK, et al. Glucagon-like peptide (GLP)-1(9- 36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. Endocrinology. 2010; 151(4):1520-1531
36. Hui H, Nourparvar A, Zhao X, Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5b-adenosine monophosphate- dependent protein kinase A- and a phosphatidylinositol 3-kinasedependent pathway. Endocrinology. 2003;144(4):1444-1455
37. Takahashi T, Tang T, Lai NC, et al. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation. 2006;114(5):388-396
38. Kwak HJ, Park KM, Choi HE, Chung KS, Lim HJ, Park HY. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways. Cell Signal. 2008;20(5):803-814
39. Sanada S, Kitakaze M, Papst PJ, et al. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase. Circulation. 2001;104(6):705-710
40. Ku HC, Chen WP, Su MJ. DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes. PLoS One. 2013;8(1):e54518
41. Gross A, Mc Donnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13(15):1899-1911
42. Reeve JL, Szegezdi E, Logue SE, et al. Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL. J Cell Mol Med. 2007;11(3):509-520
43. Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol. 1996;16(10):5546-5556
44. Meller R, Minami M, Cameron JA, et al. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab. 2005;25(2):234-246
45. Schmidt M, Evellin S, Weernink PA, et al. A new phospholipase-Ccalcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol. 2001;3(11):1020-1024
46. Oestreich EA, Malik S, Goonasekera SA, et al. Epac and phospholipase Cb regulate Ca2+elease in the heart by activation of protein kinase Cb and calcium-calmodulin kinase II. J Biol Chem. 2009; 284(3):1514-1522
47. Matsubara M, Kanemoto S, Leshnower BG, et al. Single dose GLP- 1-Tf ameliorates myocardial ischemia/reperfusion injury. J Surg Res. 2011;165(1):38-45.